Coronavírus — Tive Bronquite quando era criança, mas curei — Estou no grupo de risco mesmo assim?

Reading time: 11 min
WhatsApp ↗
Medical Encyclopedia · Allergy and Clinical Immunology

Coronavírus — Tive Bronquite quando era criança, mas curei — Estou no grupo de risco mesmo assim?

Clinical Summary and Overview

To clearly understand the clinical aspects involved in Coronavirus This is an essential step for those seeking diagnostic certainty, lasting symptom relief, and prevention of complications. In the daily practice of Allergology and Clinical Immunology, questions related to... "Coronavírus — Tive Bronquite quando era criança, mas curei — Estou no grupo de risco mesmo assim?" Allergy-free conditions are common among patients and their families. The goal of this page in the Brazil Allergy-Free Encyclopedia is to present a complete, accessible, and evidence-based medical analysis, detailing causes, immunological mechanisms, and safe practices.

✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project

Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.

Coronavírus — Tive Bronquite quando era criança, mas curei — Estou no grupo de risco mesmo assim?

Bronquite na infância e o risco frente ao coronavírus: o que você precisa saber

Uma dúvida muito comum durante a pandemia de Covid-19 surgiu de pacientes que apresentaram quadros respiratórios na infância, como a bronquite, mas que se mantiveram assintomáticos ao longo da vida adulta. Para esclarecer essa questão, é fundamental avaliar se ainda persistem sinais de hiper-reatividade brônquica ou limitação respiratória.

De maneira geral, os sintomas respiratórios podem ser classificados por níveis de intensidade:

  • Leves: falta de ar que surge apenas após esforços físicos intensos, como corridas ou atividades extenuantes.
  • Moderados: falta de ar desencadeada por esforços menores, a exemplo de uma caminhada.
  • Graves: falta de ar manifestada mesmo em repouso.

Caso o indivíduo não apresente nenhum tipo de desconforto respiratório e esteja sem sintomas há muitos anos, é provável que o perfil imunológico — relacionado ao equilíbrio entre os linfócitos e à produção adequada de anticorpos protetores, como as subclasses de IgG — esteja estabilizado. Nesses casos, não há motivos para preocupação excessiva quanto a fazer parte do grupo de risco.

A relação entre asma, infecções respiratórias e o coronavírus

Quando se aborda o pacientes com diagnóstico ativo de asma, o cenário exige uma análise dupla e cuidadosa. Por um lado, pesquisas indicam que indivíduos asmáticos podem apresentar menor expressão de receptores da enzima conversora de angiotensina 2 (ECA2) nas vias aéreas, estruturas que facilitam a entrada do vírus no organismo. Essa característica poderia, teoricamente, reduzir a facilidade de contrair a infecção.

Por outro lado, o paciente asmático já convive com uma capacidade respiratória reduzida e um quadro obstrutivo crônico. Portanto, caso ocorra a infecção e o vírus atinja o parênquima pulmonar de forma mais agressiva, o sistema respiratório já comprometido terá maior dificuldade de recuperação, aumentando o risco de complicações e necessidade de suporte intensivo.

Por esse motivo, as orientações médicas enfatizam que pacientes asmáticos jamais devem interromper o uso de seus medicamentos de controle ou das vacinas para alergia (imunoterapia alérgeno-específica) prescritas por seus especialistas. Manter os brônquios desinflamados e com a melhor função pulmonar possível é a principal estratégia de proteção.

Nota explicativa: Este conteúdo possui caráter estritamente educativo e informativo, não substituindo em hipótese alguma a consulta, o diagnóstico e a avaliação médica individualizada com um especialista do Projeto Brasil Sem Alergia ou de sua confiança.

Development in Evidence-Based Medicine: Bronchial Inflammation Control and Lung Function (GINA)

According to global guidelines of Global Initiative for Asthma (GINA), a bronchial asthma It is a chronic inflammatory disease of the airways characterized by bronchial hyperreactivity and variable obstruction to expiratory airflow, objectively documented by Spirometry (pulmonary function test with bronchodilator test)The fundamental therapeutic pillar consists of the continuous control of eosinophilic/Th2 inflammation of the bronchial mucosa through... inhaled corticosteroids (alone or in combination with long-acting beta-2 agonist bronchodilators — LABA, such as formoterol or salmeterol), using proper inhalation technique or a valved spacer. The isolated and repetitive use of short-acting bronchodilators (such as salbutamol or fenoterol) without inhaled anti-inflammatory coverage is associated with a higher risk of severe exacerbations and bronchial remodeling.

💎 Diamond Plan — Well-controlled asthma shouldn't require frequent trips to the emergency room. Talk to an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Control of Bronchial Inflammation, Lung Function, and Prevention of Remodeling

Lower Airway Hyperreactivity and the Role of Inhalation Therapy

Bronchial asthma and allergic bronchitis are chronic inflammatory diseases of the lower airways, characterized by bronchial hyperreactivity, mucosal edema, mucus hypersecretion, and variable obstruction to expiratory airflow. When eosinophilic or allergic inflammation (type 2) remains uncontrolled over the years—or when the patient uses only short-term bronchodilators without treating the underlying inflammation—thickening of the basement membrane and hypertrophy of the bronchial smooth muscle occur, a process known as bronchial remodeling.

Inhalation Technique, Environmental Control and Respiratory Immunotherapy

Periodically review the correct technique for using the inhaler device (or spacer), clean the oral cavity after applications with inhaled corticosteroids, and identify sensitizing aeroallergens through... allergy test They form the basis of modern care. asthma treatment — allied to asthma vaccine In patients allergic to house dust mites, fungi, or animal dander — it reduces inflammation of the unified airway and decreases the need for rescue medication.

Vaccine Mechanisms, Excipients, and Assessment of Immune Competence

In assessing the competence of the immune system—whether in recurrent infections, laboratory alterations in immunoglobulins (IgG, IgA, IgM, IgE), or in people living with HIV under monitoring of CD4 T lymphocyte counts—a careful distinction is made between the use of inactivated/subunit vaccines (widely safe even in immunocompromised individuals) and live attenuated vaccines, whose indication depends on the degree of preservation of cellular immunity. Furthermore, patients undergoing allergy immunotherapy can maintain their vaccination schedule, respecting only small operational intervals as directed by the medical team.

Mast Cell Activation, Histamine, and the Bradykinin Pathway

Urticaria is characterized by the sudden appearance of hives (intensely itchy, erythematous and edematous papules that are fleeting and disappear in less than 24 hours in the same spot without leaving a scar), and may be accompanied by angioedema in the deeper layers of the dermis and submucosa. In acute cases (lasting less than six weeks), viral infections, foods, and medications are among the classic triggers; while in chronic spontaneous urticaria or induced urticaria (dermographic, cholinergic due to sweat/heat, cold, or delayed pressure), autoimmune mechanisms or mast cell hyperreactivity play a central role.

Importance of Differential Diagnosis and Detailed Medical History

In the specialty of Allergy and Immunology, two patients with seemingly similar symptoms involving Coronavirus may present completely distinct pathophysiological mechanisms. For this reason, a thorough clinical history—investigating the chronology of crises, home and work environment, family history of atopy, use of concomitant medications, and dietary habits—serves as an indispensable compass for correctly interpreting laboratory tests (such as total and specific IgE levels) and functional tests. A single laboratory result can never replace in-person clinical judgment or specialized telemedicine, preventing misdiagnoses and unnecessary treatments.

Diamond Plan: Specialized Allergy Treatment Wherever You Are

SIGNATURE
DIAMOND

Allergy-Free Brazil

THE FUTURE OF TREATMENT

💎

  • Allergy and immunostimulant vaccines included.
  • Easy access (upon request)
  • Nationwide coverage — all of Brazil

brasilsemalergia.online

Treating the cause of an allergy requires consistency — and consistency requires access. Diamond Plan foi desenhado para pacientes de todo o Brasil que enfrentam o alto custo das vacinas alérgicas e as dificuldades de deslocamento, oferecendo acompanhamento especializado por telemedicina e acesso facilitado ao tratamento imunoterápico. Asma bem controlada não deveria depender de idas frequentes ao pronto-socorro.

Why do patients across Brazil choose the Diamond Plan?

  • Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
  • easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
  • A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
  • Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
  • National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.

More than 30 years caring for people with allergies.

Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.

START TODAY

Your expert consultation is just a click away.

I want to join the Diamond Plan.Schedule a teleconsultation

Official telemedicine environment: brasilsemalergia.online

Do you prefer to be served in person?

Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:

Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.

The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Conclusion and Summary of Guidelines

In summary, the appropriate approach to Coronavirus It requires a clear understanding of the immunological mechanisms involved, precise etiological diagnosis, and individualized medical follow-up. Avoiding self-medication and investigating the root cause of symptoms—relying on specialized resources and reliable guidance such as specialized allergy and immunology care when clinically relevant—is the safest way to control flare-ups, prevent complications, and ensure sustainable quality of life.

Scientific references and authoritative sources

The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information: